InspireMD (NASDAQ: NSPR) reported Q3 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $1.81 million versus the consensus estimate of $1.74 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.